Beijing Centergate Technologies (holding) Co., Ltd.
000931.SZ · SHZ
Market closed4.22-0.170000 (-3.87%)
Key statistics
Previous close4.39
Open4.34
Day high4.45
Day low4.22
52-week high5.86
52-week low3.91
Market cap3.18B
Volume13.02M
Average volume9.76M
P/E ratio118.57
Forward P/E—
EPS0.04
Dividend yield+0.47%
Market context
Why it moved
Shares of 中关村 (000931.SZ) declined sharply as market sentiment turned cautious, even as its subsidiary received regulatory acceptance of a new drug application for ivabradine hydrochloride tablets from China's National Medical Products Administration, with investors apparently viewing the near-term commercial impact as limited or already priced in.
What is happening
Recent company-specific developments and publisher coverage.
TradingView · July 15, 2026Enterprise value to revenue forward of Beijing Centergate Technologies (Holding) Co., Ltd Class A – SZSE:000931TradingView · July 11, 2026Price to earnings forward of Beijing Centergate Technologies (Holding) Co., Ltd Class A – SZSE:000931 Mt Newswire · February 9, 2026Beijing Centergate Technologies to Build Traditional Chinese Medicine Factory Mt Newswire · January 7, 2026Centergate Technologies Green Lights Indirect Subsidiary's Collateral for 45 Million Yuan Credit